Bhavatarini Vangamudi

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi, Thomas A. Paul, Parantu K. Shah et al. · Cancer Research · 2015 · 266 citations · Full text

Atpase Domain, Exclusive Catalytic Subunits, Drug Target +17

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

Virginia Giuliani, Meredith A. Miller, Chiu-Yi Liu et al. · Nature Communications · 2021 · 71 citations · Full text

Discovery of a Potent Inhibitor of Replication Protein A Protein–Protein Interactions Using a Fragment-Linking Approach

Andreas O. Frank, Michael D. Feldkamp, J. Phillip Kennedy et al. · Journal of Medicinal Chemistry · 2013 · 67 citations · Full text

Protein Chemistry, Nmr Spectroscopy, Biochemistry +15

Discovery of a Potent Stapled Helix Peptide That Binds to the 70N Domain of Replication Protein A

Andreas O. Frank, Bhavatarini Vangamudi, Michael D. Feldkamp et al. · Journal of Medicinal Chemistry · 2014 · 48 citations · Full text

Protein Assembly, Unnatural Amino Acid, Peptide Engineering +17

t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer

Bhavatarini Vangamudi, Dunfa Peng, Qiuyin Cai et al. · Molecular Cancer · 2010 · 46 citations · Full text